Overview

Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT)

Status:
Completed
Trial end date:
1996-08-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of a human anti-CMV monoclonal antibody, MSL-109, as adjunct therapy for controlling CMV retinitis.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Johns Hopkins Bloomberg School of Public Health
Treatments:
Antibodies
Antibodies, Monoclonal
Immunoglobulins